KALA BIO, Inc. KALA
Set alert
0.18 USD +0.01 +6.52%
As of Nov 3, 2:52 PM ET
0.1664 Day range 0.1798
0.115 52-week range 95.50
- YTD
- -99.36%
- 1 year
- -99.53%
- Open
- 0.1666
- Prev close
- 0.1672
- Mkt cap
- 3.42M
- Vol
- 148.40K
- Avg vol
- 1.51M
- EPS
- -10.71
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.1664
- High
- 0.1798
- Forward P/E
- -0.90
- Beta
- -2.14
- Short ratio
- 1.91
- Inst. own
- 48.13%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 6.42
- 200-d avg
- 6.50
- 1y target
- 15.00
3M chart
Signals (10)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 22, 2026 | 1 week ago |
| RSI: Oversold | Oct 5, 2026 | 4 weeks ago |
| MACD: Sell Signal | Oct 2, 2026 | 1 month ago |
| RSI: Oversold | Sep 15, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 10, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 2, 2026 | 2 months ago |
| RSI: Oversold | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| SMA: Bullish | Aug 13, 2026 | 2 months ago |
| RSI: Oversold | Aug 4, 2026 | 3 months ago |
Analyst view
Price target (mean) 15.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -2.47 | -2.47 – -2.47 | -1.58 | -56.2% | 0 | 0.0% | 1 |
| Next quarter | -2.57 | -2.57 – -2.57 | -3.19 | +19.3% | 0 | 0.0% | 1 |
| Current year | -11.07 | -11.07 – -11.07 | -13.43 | +17.6% | 0 | 0.0% | 1 |
| Next year | -6.02 | -6.02 – -6.02 | -11.07 | +45.6% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 19, 2024 | Oppenheimer | Reiterated | Outperform | Outperform |
| May 17, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 2, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 1, 2024 | Oppenheimer | Reiterated | Outperform | Outperform |
| Nov 17, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 11, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 10, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| May 1, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Apr 12, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 27, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 6, 2023 | HC Wainwright & Co. | Maintained | — | Buy |